*In clinical trials studying Wegovy (2.4 mg), the average weight loss was 15% and 20%, respectively, when paired with diet and exercise (compared to 2.4% and 3.1% with diet and exercise alone)
Tests examining variants in GLP1R, GIPR, and FTO pathways may provide clinical contextthough these reveal predispositions, not exact medication response
- The anti-ALK, anti-TRKA, anti-MET, anti-HRAS-WT, and anti-ROS1 antibodies identify the subset of melanocytic tumors of the Spitz lineage with the respective kinase gene changes (48, 83, 84)
Ozempic (Semaglutide) is effectively used for diabetes and weight loss, but clinical reports link it to specific eyelid conditions including blepharitis (inflammation) and eyelid dermatitis
Individuals seeking support for weight management, growth hormone deficiency, or metabolic conditions are encouraged to engage with their GP or a specialist endocrinologist, who can assess eligibility for licensed treatments through appropriate clinical pathways
& Carver, J